Skip to Main Content

Latest Published Articles

Antimicrobial stewardship markers and healthcare-associated pneumonia threshold criteria in UK hospitals: analysis of the MicroGuideTm application
Luke S P Moore and others
Background To address antimicrobial resistance, antimicrobial stewardship (AMS) principles must be implemented and adhered to. Clinical decision aids such as the MicroGuide TM app are an important part of these efforts. We sought to evaluate the consistency of core AMS information and the diversity ...
Selection of proxy indicators estimating the appropriateness of antibiotic prescriptions in general practice: a national consensus procedure in France
Maïa Simon and others
Background GPs are responsible for more than 70% of outpatient antibiotic prescriptions in France. Metrics are important antibiotic stewardship tools that can be used to set targets for improvement and to give feedback to professionals and stakeholders. Objectives The primary objective of the ...
Antibiotic prescribing practices of medical doctors in a resource-limited setting and the influence of individual perceptions and stewardship support: a survey in three tertiary hospitals in Vietnam
Huong Thi Lan Vu and others
Objectives To understand antibiotic prescribing and influencing factors to inform antimicrobial stewardship (AMS) interventions to reduce unwanted consequences of antibiotic use in hospitals in Vietnam, a lower-middle-income country in Asia. Methods We conducted a cross-sectional study of doctors ...
The MIC distribution of dalbavancin differs between different coagulase-negative staphylococci
Sara Svensson and others
Background CoNS constitute a significant part of the human microbiota of skin and mucous membranes. They can cause nosocomial infections, and have shown decreased susceptibility to several antibiotics. The few remaining treatment options include (lipo)glycopeptides such as dalbavancin. However, ...
Heteroresistance to piperacillin/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple β-lactamase genes
Ahmed Babiker and others
Background Piperacillin/tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad spectrum of activity that is often used as empirical and/or targeted therapy among hospitalized patients. Heteroresistance (HR) is a form of antibiotic resistance in which a minority population of ...

Most read

Review Article
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007–18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK ...
Review Article
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Extended-spectrum β-lactamase (ESBL)-producing Gram-negative pathogens are a major cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the early 1980s, they have spread worldwide and an are now endemic in Enterobacterales isolated from both hospital-associated and community-acquired ...
Research Article
High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)
Objectives Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is a global public health concern. Ceftriaxone is the last effective and recommended option for empirical gonorrhoea therapy worldwide, but several ceftriaxone-resistant cases linked to Asia have been reported internationally. During January 2022–June 2023, ...
Research Article
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework
Objectives To evaluate the stability of ceftazidime/avibactam in elastomeric infusers, utilizing the UK’s Yellow Cover Document (YCD) stability testing framework, in conditions representative of OPAT practice. Methods Ceftazidime/avibactam was reconstituted with sodium chloride 0.9% (w/v) in two elastomeric infusers at ...
Review Article
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK
UK good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) were published in 2012 and 2015 for adult and paediatric patients, respectively. Here we update the initial good practice recommendations in a combined document based on a further review of the OPAT literature and an extensive ...
Publish with JAC-AMR

Why publish with JAC-AMR?

Explore publishing with JAC-Antimicrobial Resistance.*

  • 33 days to first decision
  • 12 days in review
  • 19 days from acceptance to advance access publication

*Average manuscript processing times. 

Learn more

Meet the Editorial Board

Find out more about JAC-Antimicrobial Resistance’s distinguished Editorial Board, led by Editor-in-Chief Dr David van Duin.

Learn more

Read and publish

Read and Publish deals

Authors interested in publishing in JAC-Antimicrobal Resistance may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP.

Find out if your institution is participating

Email alerts

Register to receive table of contents email alerts as soon as new issues of JAC-Antimicrobal Resistance are published online.

Sign up

 

Developing countries initiative

Developing countries initiative

Your institution could be eligible to free or deeply discounted online access to JAC-Antimicrobal Resistance through the Oxford Developing Countries Initiative.

Find out more

BSAC

The British Society for Antimicrobial Chemotherapy

The British Society for Antimicrobial Chemotherapy is an inter-professional organisation with over 40 years of experience and achievement in antibiotic education, research and leadership. Dedicated to saving lives through appropriate use and development of antibiotics now and in the future.

Find out more

APC Discount

BSAC Members automatically receive a 20% discount on our standard article processing charge (APC). If you aren’t yet a member, head over to the our Membership section - membership is free and only takes a couple of minutes apply, so there's never been a better time to join us! 

Join BSAC today

Altmetrics

Discover a more complete picture of how readers engage with research in JAC-Antimicrobal Resistance through Altmetric data. Now available on article pages.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close